Cumberland Pharma soars on FDA approval for paracetamol overdose drug

Cumberland Pharmaceuticals

10/12/2024 10:25

** Shares of drugmaker Cumberland Pharmaceuticals  CPIX.O 
rise ~108% to $2.57 premarket
    ** CPIX said on Monday the U.S. FDA approved co's
supplemental new drug application to treat paracetamol overdose
    ** Paracetamol, chemically known as acetaminophen, is the
leading cause of acute liver failure in the U.S. - CPIX
    ** The drug, branded as Acetadote, simplifies dosing and
reduces risk of medication errors while staying effective - co
    ** As of last close, stock had fallen 30.7% YTD

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com;))